HRMY - Latest News

Harmony Biosciences Holdings, Inc. (HRMY), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $2.18B. Trailing twelve-month P/E ratio is 11.98. Beta to the broader market is 1.01.

The article list below shows the most recent HRMY headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent HRMY Headlines

Why Harmony Biosciences Stock Got Mashed on Monday

fool.com - Oct 12, 2026

Investors weren't cheered by a major change in the company's leadership.

Harmony Biosciences (NASDAQ:HRMY) Shares Gap Down – What’s Next?

defenseworld.net - Oct 12, 2026

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY - Get Free Report) gapped down prior to trading on Monday.

Head to Head Review: Harmony Biosciences (NASDAQ:HRMY) versus PainReform (NASDAQ:PRFX)

defenseworld.net - Oct 12, 2026

Harmony Biosciences (NASDAQ: HRMY - Get Free Report) and PainReform (NASDAQ: PRFX - Get Free Report) are both healthcare companies, but which is the s

Harmony Bio CEO Plans His Exit, And Shares Take An Unharmonious Hit

investors.com - Oct 12, 2026

Harmony Biosciences stock took a tumble Monday after its announced the transition of current CEO Jeffrey Dayno at the end of the year.

HRMY vs. CSLLY: Which Stock Is the Better Value Option?

zacks.com - Oct 6, 2026

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Biosciences Holdings, Inc. (HRMY) and CSL Limited S

How News Affects HRMY Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track HRMY's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked HRMY news questions

What is the latest HRMY news headline?

The most recent HRMY headline (Oct 12, 2026) is "Why Harmony Biosciences Stock Got Mashed on Monday". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the HRMY news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What HRMY news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual HRMY options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.